Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital diabetes coach put to the test – but trial ends early

NCT ID NCT05026528

Disease control Sponsor: Region Jönköping County Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a digital system called 'Live well with type 2 diabetes' to help people manage their condition. It compared the digital program to usual care for 138 adults recently diagnosed with type 2 diabetes. The main goal was to see if it improved blood sugar levels. However, the trial was terminated, so we don't have clear results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital diabetes self-management education and support system
What this could lead to
If successful, this could show that digital tools help people with type 2 diabetes manage their blood sugar better.
What could go wrong
The trial was terminated early, so we don't have clear results. It's unclear if the digital system works better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

138 people

The number who actually took part.

Started

Nov 2021

Finished

Apr 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Type 2 diabetes mellitus diagnosed according to WHO criteria \< 5 years from randomization: * Fasting plasma glucose \> 7 mmol/L at two timepoints. OR * HbA1c ≥ 48 mmol/mol twice or in combination with fasting plasma glucose \> 7 mmo/L once. OR * Non-fasting plasma glucose ≥ 11.1 mmol/L at one timepoint in combination with symptoms of hyperglycemia. * Access to a digital ID-card to access the digital system * Access to a computer, tablet or smart phone * Sufficient knowledge of written and spoken Swedish to understand the information given in the digital system. Exclusion Criteria: * Treatment with Insulin * Other co-morbidities limiting the use of the digital system according to the diabetes nurse judgement. E.g. dementia or severe psychiatric disease. * Other forms of diabetes mellitus than type 2 diabetes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

Contacts and locations

Locations

  • Aroma Vårdcentral

    Vetlanda, Sweden

  • Boxholms vårdcentral

    Boxholm, Sweden

  • Eksjö vårdcentral

    Eksjö, Sweden

  • Gislaved vårdcentral

    Gislaved, Sweden

  • Gränna vårdcentral

    Jönköping, Sweden

  • Kvarnholmens hälsocentral

    Kalmar, Sweden

  • Kärna vårdcentral

    Linköping, Sweden

  • Linghems vårdcentral

    Linköping, Sweden

  • Lokstallarna vårdcentral

    Jönköping, Sweden

  • Norrahammars vårdcentral

    Jönköping, Sweden

  • Rosenhälsans vårdcentral

    Huskvarna, Sweden

  • Råslätts vårdcentral

    Jönköping, Sweden

  • Stora Trädgårdsgatans hälsocentral

    Västervik, Sweden

  • Tannefors vårdcentral

    Linköping, Sweden

  • Wetterhälsan

    Jönköping, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.